Narrow band imaging as a noninvasive tool for evaluation of the severity of inflammation in patients with ulcerative colitis in Kafr-El-Sheikh university, Egypt.

Objectives: To analyse the effectiveness of narrow-band imaging in determining the severity of inflammation in ulcerative colitis patients in relation to histological activity. Method: The cross-sectional study was conducted at Kafrelsheikh University Hospital, Egypt, from June 2021 to May 2022, and comprised patientsregardless of age and gender who had ulcerative colitis and visited the endoscopy unit. After taking detailed history, the patients were subjected to physical examination and laboratory tests which included complete blood count, international normalised ratio, erythrocyte sedimentation rate and faecal calprotectin. Colonoscopy with narrow-band imaging, biopsy and histopathological assessment were done as part of clinical evaluation. Data was analysed using SPSS 20. RESULTS: Of the 100 patients, 55(55%) were male and 45(45%) were females. The overall mean age was 33.72±10.29 years (range: 11-56 years). There were 73(73%) patients who were married, 12(12%) had positive family history and 19(19%) were smokers. Besides, 18(18%) patientsreceived biological therapy. There wassignificant positive correlation between histopathological and endoscopic scores(p<0.05). Also, there was a significant positive correlation between histopathologicalscore and findings of narrow-band imaging (p<0.05). There were 10(10%) patients who were found to have dysplasia that was not diagnosed with colonoscopy. CONCLUSIONS: Narrow-band imaging was found to have a significant correlation with the histologically determined degree of inflammation.

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis.

BACKGROUND AND AIM: Liver cirrhosis (LC) is commonly associated with portal hypertensive gastropathy (PHG), and it causes gastrointestinal (GI) bleeding. Esophagogastroduodenoscopy (EGD) is the gold standard in diagnosing PHG. Besides its invasiveness, the disadvantages of EGD include psychological and financial problems. We aimed to evaluate the diagnostic accuracy of different noninvasive screening tools in predicting PHG. METHODS: This cross-sectional study was conducted on 100 patients with LC who were divided into two groups based on EGD: group (A), 50 patients with LC with PHG, and group (B), 50 patients with LC without PHG. All patients were subjected to history taking, full clinical examination, laboratory investigations, abdominal-pelvic ultrasonography, and EGD. RESULTS: To predict PHG, the respective sensitivity and specificity of portal vein diameter (>10.5 mm) were 86 and 67%, of gallbladder wall thickness (GBWT) (>3.5 mm) were 64 and 68%, of platelets/GBWT (<40) were 68 and 78%, of aspartate aminotransferase (AST)/platelet ratio index (APRI) score (>1.1) were 60 and 66%, of platelet/spleen diameter (<1290) were 88 and 72%, of right liver lobe diameter/albumin ratio (>4) were 74 and 80%, and of AST/alanine aminotransferase (ALT) ratio (>1.1) were 50 and 58% (P = 0.353). CONCLUSION: Portal vein diameter, platelet/spleen diameter, and right liver lobe diameter/albumin ratio were independently associated with PHG and were good predictors of the PHG, whereas AST/ALT ratio and King score are poor predictors.